DALLAS, June 20, 2012 (GLOBE NEWSWIRE) -- Three approaches may reverse the blood thinning action of the new oral anticoagulant drug apixaban when a person suffers an accident or needs emergency surgery, according to laboratory research presented in the American Heart Association's Emerging Science Series webinar.
